New Biosimilar Guidelines to ease Bioequivalence Study Norms: DCGI, ETPharma
New Delhi: The upcoming guidance for the development and manufacturing of biosimilar drugs in India will reduce the…
90 FDC drug samples, including Paracetamol, found unapproved; regulator asks states to take action
NEW DELHI: The Drug Controller General of India (DCGI) has launched a nationwide crackdown on unapproved Fixed Dose…
India restricts sale of off-patent TB medicines to government channels to combat drug resistance
New Delhi: India will make new and off-patent tuberculosis drugs available only through government channels to curb resistance…